UNITED NATURAL FOODS INC 10-Q

Item 1. Financial Statements UNITED NATURAL FOODS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (in millions, except for par values) January 27, 2024 July 29, 2023 ASSETS Cash and cash equivalents $ 34 $ 37 Accounts receivable, net 990 889 Inventories, net 2,311 2,292 Prepaid expenses and other current assets 246 245 Total current assets 3,581 3,463 Property and equipment, net 1,766 1,767 Operating lease assets 1,430 1,228 Goodwill 20 20 Intangible assets, net 685 722 Deferred income taxes 34 32 Other long-term assets 155 162 Total assets $ 7,671 $ 7,394 LIABILITIES AND STOCKHOLDERS’ EQUITY Accounts payable $ 1,722 $ 1,781 Accrued expenses and other current liabilities 247 283 Accrued compensation and benefits 168 143 Current portion of operating lease liabilities 187 180 Current portion of long-term debt and finance lease liabilities 12 18 Total current liabilities 2,336 2,405 Long-term debt 2,176 1,956 Long-term operating lease liabilities 1,298 1,099 Long-term finance lease liabilities 7 12 Pension and other postretirement benefit obligations 15 16 Other long-term liabilities 147 162 Total liabilities 5,979 5,650 Commitments and contingencies Stockholders’ equity: Preferred stock, $ 0.01 par value, authorized 5.0 shares; none issued or outstanding — — Common stock, $ 0.01 par value, authorized 100.0 shares; 61.9 shares issued and 59.4 shares outstanding at January 27, 2024; 61.0 shares issued and 58.5 shares outstanding at July 29, 2023 1 1 Additional paid-in capital 616 606 Treasury stock at cost ( 86 ) ( 86 ) Accumulated other comprehensive loss ( 35 ) ( 28 ) Retained earnings 1,196 1,250 Total United Natural Foods, Inc. stockholders’ equity 1,692 1,743 Noncontrolling interests — 1 Total stockholders’ equity 1,692 1,744 Total liabilities and stockholders’ equity $ 7,671 $ 7,394 See accompanying Notes to Condensed Consolidated Financial Statements. 3 Table of Contents UNITED NATURAL FOODS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) (in millions, except for per share data) 13-Week Period Ended 26-Week Period Ended January 27, 2024 January 28, 2023 January 27, 2024 January 28, 2023 Net sales $ 7,775 $ 7,816 $ 15,327 $ 15,348 Cost of sales 6,740 6,747 13,262 13,183 Gross profit 1,035 1,069 2,065 2,165 Operating expenses 1,010 1,002 2,033 2,002 Restructuring, acquisition and integration related expenses 4 3 8 5 Loss (gain) on sale of assets and other asset charges 5 1 24 ( 4 ) Operating income 16 63 — 162 Net periodic benefit income, excluding service cost ( 4 ) ( 7 ) ( 7 ) ( 14 ) Interest expense, net 40 39 75 74 Other income, net ( 1 ) — ( 1 ) ( 1 ) (Loss) income before income taxes ( 19 ) 31 ( 67 ) 103 (Benefit) provision for income taxes ( 5 ) 9 ( 14 ) 14 Net (loss) income including noncontrolling interests ( 14 ) 22 ( 53 ) 89 Less net income attributable to noncontrolling interests ( 1 ) ( 3 ) ( 1 ) ( 4 ) Net (loss) income attributable to United Natural Foods, Inc. $ ( 15 ) $ 19 $ ( 54 ) $ 85 Basic (loss) earnings per share $ ( 0.25 ) $ 0.32 $ ( 0.92 ) $ 1.43 Diluted (loss) earnings per share $ ( 0.25 ) $ 0.31 $ ( 0.92 ) $ 1.38 Weighted average shares outstanding: Basic 59.4 59.8 59.0 59.3 Diluted 59.4 61.0 59.0 61.3 See accompanying Notes to Condensed Consolidated Financial Statements. 4 Table of Contents UNITED NATURAL FOODS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (unaudited) (in millions) 13-Week Period Ended 26-Week Period Ended January 27, 2024 January 28, 2023 January 27, 2024 January 28, 2023 Net (loss) income including noncontrolling interests $ ( 14 ) $ 22 $ ( 53 ) $ 89 Other comprehensive (loss) income: Recognition of pension and other postretirement benefit obligations, net of tax 1 1 1 1 Recognition of interest rate swap cash flow hedges, net of tax (1) ( 4 ) ( 4 ) ( 7 ) 14 Foreign currency translation adjustments 2 1 ( 1 ) ( 2 ) Recognition of other cash flow derivatives, net of tax (2) ( 1 ) ( 2 ) — ( 2 ) Total other comprehensive (loss) income ( 2 ) ( 4 ) ( 7 ) 11 Less comprehensive income attributable to noncontrolling interests ( 1 ) ( 3 ) ( 1 ) ( 4 ) Total comprehensive (loss) income attributable to United Natural Foods, Inc. $ ( 17 ) $ 15 $ ( 61 ) $ 96 (1) Amounts are net of tax (benefit) expense of $( 1 ) million and $( 1 ) million for the second quarters of fiscal 2024 and 2023, respectively, and $( 2 ) million and $ 5 million for fiscal 2024 and 2023 year-to-date, respectively. (2) Amounts are net of tax (benefit) expense of $ 0 million and $( 1 ) million for the second quarters of fiscal 2024 and 2023, respectively, and $ 0 million and $( 1 ) million for fiscal 2024 and 2023 year-to-date, respectively. See accompanying Notes to Condensed Consolidated Financial Statements. 5 Table of Contents UNITED NATURAL FOODS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (unaudited) For the 13-week periods ended January 27, 2024 and January 28, 2023 (in millions) Common Stock Treasury Stock Additional Paid-in Capital Accumulated Other Comprehensive Loss Retained Earnings Total United Natural Foods, Inc. Stockholders’ Equity Noncontrolling Interests Total Stockholders’ Equity Shares Amount Shares Amount Balances at October 28, 2023 61.9 $ 1 2.5 $ ( 86 ) $ 606 $ ( 33 ) $ 1,211 $ 1,699 $ — $ 1,699 Share-based compensation — — — — 10 — — 10 — 10 Other comprehensive loss — — — — — ( 2 ) — ( 2 ) — ( 2 ) Distributions to noncontrolling interests — — — — — — — — ( 1 ) ( 1 ) Net (loss) income — — — — — — ( 15 ) ( 15 ) 1 ( 14 ) Balances at January 27, 2024 61.9 $ 1 2.5 $ ( 86 ) $ 616 $ ( 35 ) $ 1,196 $ 1,692 $ — $ 1,692 Balances at October 29, 2022 60.9 $ 1 1.0 $ ( 36 ) $ 583 $ ( 5 ) $ 1,292 $ 1,835 $ — $ 1,835 Restricted stock vestings — — — — ( 2 ) — — ( 2 ) — ( 2 ) Share-based compensation — — — — 11 — — 11 — 11 Repurchases of common stock — — 0.3 ( 17 ) — — — ( 17 ) — ( 17 ) Other comprehensive loss — — — — — ( 4 ) — ( 4 ) — ( 4 ) Net income — — — — — — 19 19 3 22 Balances at January 28, 2023 60.9 $ 1 1.3 $ ( 53 ) $ 592 $ ( 9 ) $ 1,311 $ 1,842 $ 3 $ 1,845 See accompanying Notes to Condensed Consolidated Financial Statements. 6 Table of Contents UNITED NATURAL FOODS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (unaudited) For the 26-week periods ended January 27, 2024 and January 28, 2023 (in millions) Common Stock Treasury Stock Additional Paid-in Capital Accumulated Other Comprehensive Loss Retained Earnings Total United Natural Foods, Inc. Stockholders’ Equity Noncontrolling Interests Total Stockholders’ Equity Shares Amount Shares Amount Balances at July 29, 2023 61.0 $ 1 2.5 $ ( 86 ) $ 606 $ ( 28 ) $ 1,250 $ 1,743 $ 1 $ 1,744 Restricted stock vestings 0.9 — — — ( 6 ) — — ( 6 ) — ( 6 ) Share-based compensation — — — — 16 — — 16 — 16 Other comprehensive loss — — — — — ( 7 ) — ( 7 ) — ( 7 ) Distributions to noncontrolling interests — — — — — — — — ( 2 ) ( 2 ) Net (loss) income — — — — — — ( 54 ) ( 54 ) 1 ( 53 ) Balances at January 27, 2024 61.9 $ 1 2.5 $ ( 86 ) $ 616 $ ( 35 ) $ 1,196 $ 1,692 $ — $ 1,692 Balances at July 30, 2022 58.9 $ 1 0.6 $ ( 24 ) $ 608 $ ( 20 ) $ 1,226 $ 1,791 $ 1 $ 1,792 Restricted stock vestings 2.0 — — — ( 39 ) — — ( 39 ) — ( 39 ) Share-based compensation — — — — 23 — — 23 — 23 Repurchases of common stock — — 0.7 ( 29 ) — — — ( 29 ) — ( 29 ) Other comprehensive income — — — — — 11 — 11 — 11 Distributions to noncontrolling interests — — — — — — — — ( 2 ) ( 2 ) Net income — — — — — — 85 85 4 89 Balances at January 28, 2023 60.9 $ 1 1.3 $ ( 53 ) $ 592 $ ( 9 ) $ 1,311 $ 1,842 $ 3 $ 1,845 See accompanying Notes to Condensed Consolidated Financial Statements. 7 Table of Contents UNITED NATURAL FOODS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) 26-Week Period Ended (in millions) January 27, 2024 January 28, 2023 CASH FLOWS FROM OPERATING ACTIVITIES: Net (loss) income including noncontrolling interests $ ( 53 ) $ 89 Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: Depreciation and amortization 152 147 Share-based compensation 16 23 Gain on sale of assets ( 7 ) ( 9 ) Long-lived asset impairment charges 21 — Net pension and other postretirement benefit income ( 7 ) ( 14 ) Deferred income tax expense — 1 LIFO charge 13 50 Provision (recoveries) for losses on receivables 2 ( 3 ) Non-cash interest expense and other adjustments 5 8 Changes in operating assets and liabilities ( 213 ) ( 22 ) Net cash (used in) provided by operating activities ( 71 ) 270 CASH FLOWS FROM INVESTING ACTIVITIES: Payments for capital expenditures ( 141 ) ( 151 ) Proceeds from dispositions of assets 11 12 Payments for investments ( 12 ) ( 4 ) Net cash used in investing activities ( 142 ) ( 143 ) CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from borrowings under revolving credit line 1,422 1,944 Proceeds from issuance of other loans 14 — Repayments of borrowings under revolving credit line ( 1,180 ) ( 1,861 ) Repayments of long-term debt and finance leases ( 37 ) ( 143 ) Repurchases of common stock — ( 29 ) Payments of employee restricted stock tax withholdings ( 6 ) ( 39 ) Distributions to noncontrolling interests ( 2 ) ( 2 ) Repayments of other loans — ( 1 ) Other ( 1 ) — Net cash provided by (used in) financing activities 210 ( 131 ) EFFECT OF EXCHANGE RATE ON CASH — — NET DECREASE IN CASH AND CASH EQUIVALENTS ( 3 ) ( 4 ) Cash and cash equivalents, at beginning of period 37 44 Cash and cash equivalents, at end of period $ 34 $ 40 Supplemental disclosures of cash flow information: Cash paid for interest $ 74 $ 65 Cash (refunds) payments for federal, state, and foreign income taxes, net $ ( 13 ) $ 3 Leased assets obtained in exchange for new operating lease liabilities $ 298 $ 133 Additions of property and equipment included in Accounts payable $ 31 $ 31 See accompanying Notes to Condensed Consolidated Financial Statements. 8 Table of Contents UNITED NATURAL FOODS, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited) NOTE 1—SIGNIFICANT ACCOUNTING POLICIES Nature of Business United Natural Foods, Inc. and its subsidiaries (the “Company” or “UNFI”) is a leading distributor of natural, organic, specialty, produce and conventional grocery and non-food products, and provider of support services to retailers. The Company sells its products primarily throughout the United States and Canada. Fiscal Year The Company’s fiscal years end on the Saturday closest to July 31 and contain either 52 or 53 weeks. Fiscal 2024 will contain 53 weeks with the fourth quarter of fiscal 2024 containing 14 weeks. References to the second quarter of fiscal 2024 and 2023 relate to the 13-week fiscal quarters ended January 27, 2024 and January 28, 2023, respectively. References to fiscal 2024 and 2023 year-to-date relate to the 26-week fiscal periods ended January 27, 2024 and January 28, 2023, respectively. Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation. The accompanying unaudited Condensed Consolidated Financial Statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial information, including the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, certain information and note disclosures normally required in complete financial statements prepared in conformity with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted. In the Company’s opinion, these Condensed Consolidated Financial Statements include all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. However, the results of operations for interim periods may not be indicative of the results that may be expected for a full year. These Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended July 29, 2023 (the “Annual Report”). There were no material changes in significant accounting policies from those described in the Annual Report. Use of Estimates The preparation of the Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Reclassifications Within the Condensed Consolidated Financial Statements certain immaterial amounts have been reclassified to conform with current period presentation. These reclassifications had no impact on reported net income, cash flows, or total assets and liabilities. Cash and Cash Equivalents Cash equivalents consist of highly liquid investments with original maturities of three months or less. The Company’s banking arrangements allow it to fund outstanding checks when presented to the financial institution for payment. The Company funds all intraday bank balance overdrafts during the same business day. Checks outstanding in excess of bank balances create book overdrafts, which are recorded in Accounts payable in the Condensed Consolidated Balance Sheets and are reflected as an operating activity in the Condensed Consolidated Statements of Cash Flows. As of January 27, 2024 and July 29, 2023, the Company had net book overdrafts of $ 283 million and $ 308 million, respectively. 9 Table of Contents Inventories, Net Substantially all of the Company’s inventories consist of finished goods. To value discrete inventory items at lower of cost or net realizable value before application of any last-in, first-out (“LIFO”) reserve, the Company utilizes the weighted average cost method, perpetual cost method, the retail inventory method and the replacement cost method. Allowances for vendor funds and cash discounts received from suppliers are recorded as a reduction to Inventories, net and subsequently within Cost of sales upon the sale of the related products. Inventory quantities are evaluated throughout each fiscal year based on physical counts in the Company’s distribution facilities and stores. Allowances for inventory shortages are recorded based on the results of these counts. The LIFO reserve was approximately $ 357 million and $ 344 million as of January 27, 2024 and July 29, 2023, respectively, which is recorded within Inventories, net on the Condensed Consolidated Balance Sheets. NOTE 2—RECENTLY ADOPTED AND ISSUED ACCOUNTING PRONOUNCEMENTS Recently Issued Accounting Pronouncements In June 2022, the Financial Accounting Standards Board (“FASB”) issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions . ASU 2022-03 clarifies that a contractual restriction on the sale of an equity security is not part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The amendments in this update also require additional disclosures for equity securities subject to contractual sale restrictions. The Company is required to adopt the amendments in this update in the first quarter of fiscal 2025. The Company is in the process of reviewing the provisions of the amendments in this update but does not expect the adoption to have a material impact on the Company’s consolidated financial statements. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures . ASU 2023-07 requires disclosure of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”) and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items to reconcile to segment profit or loss, and the title and position of the entity’s CODM. The amendments in this update also expand the interim segment disclosure requirements. The Company is required to adopt the amendments in this update in fiscal 2025, and the interim disclosure requirements will be effective for the Company in the first quarter of fiscal 2026. Early adoption is permitted. The amendments in this update are required to be applied on a retrospective basis. The Company is currently reviewing the provisions of the amendments in this update and evaluating their impact on the Company’s consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures . ASU 2023-09 requires disclosure of specific categories in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold. The amendments also require disclosure on an annual basis of income taxes paid disaggregated by federal, state and foreign taxes as well as the amount of income taxes paid by individual jurisdiction. In addition, the amendments require disclosures of disaggregated pretax income and income tax expense and remove the requirement to disclose certain items that are no longer considered cost beneficial or relevant. The Company is required to adopt the amendments in this update in fiscal 2026. Early adoption is permitted. The amendments in this update should be applied on a prospective basis, but can also be applied retrospectively. The Company is currently reviewing the provisions of the amendments in this update and evaluating their impact on the Company’s consolidated financial statements. NOTE 3—REVENUE RECOGNITION Disaggregation of Revenues The Company records revenue to five customer channels within Net sales, which are described below: • Chains , which consists of customer accounts that typically have more than 10 operating stores and excludes stores included within the Supernatural and Other channels defined below; • Independent retailers , which includes smaller size accounts including single store and multiple store locations, and group purchasing entities that are not classified within Chains above or Other defined below; • Supernatural , which consists of chain accounts that are national in scope and carry primarily natural products, and currently consists solely of one customer; • Retail , which reflects the Company’s Retail segment, including Cub® Foods and Shoppers® stores; and • Other , which includes international customers outside of Canada, foodservice, eCommerce, conventional military business and other sales. 10 Table of Contents The following tables detail the Company’s Net sales for the periods presented by customer channel for each of its segments. The Company does not record its revenues within its Wholesale reportable segment for financial reporting purposes by product group, and it is therefore impracticable for it to report them accordingly. Net Sales for the 13-Week Period Ended (in millions) January 27, 2024 Customer Channel Wholesale Retail Other Eliminations (1) Consolidated Chains $ 3,266 $ — $ — $ — $ 3,266 Independent retailers 1,907 — — — 1,907 Supernatural 1,751 — — — 1,751 Retail — 631 — — 631 Other 563 — 52 — 615 Eliminations — — — ( 395 ) ( 395 ) Total $ 7,487 $ 631 $ 52 $ ( 395 ) $ 7,775 Net Sales for the 13-Week Period Ended (in millions) January 28, 2023 Customer Channel Wholesale Retail Other Eliminations (1) Consolidated Chains $ 3,322 $ — $ — $ — $ 3,322 Independent retailers 1,980 — — — 1,980 Supernatural 1,659 — — — 1,659 Retail — 660 — — 660 Other 553 — 56 — 609 Eliminations — — — ( 414 ) ( 414 ) Total $ 7,514 $ 660 $ 56 $ ( 414 ) $ 7,816 Net Sales for the 26-Week Period Ended (in millions) January 27, 2024 Customer Channel Wholesale Retail Other Eliminations (1) Consolidated Chains $ 6,450 $ — $ — $ — $ 6,450 Independent retailers 3,806 — — — 3,806 Supernatural 3,363 — — — 3,363 Retail — 1,237 — — 1,237 Other 1,149 — 112 — 1,261 Eliminations — — — ( 790 ) ( 790 ) Total $ 14,768 $ 1,237 $ 112 $ ( 790 ) $ 15,327 Net Sales for the 26-Week Period Ended (in millions) January 28, 2023 Customer Channel Wholesale Retail Other Eliminations (1) Consolidated Chains $ 6,546 $ — $ — $ — $ 6,546 Independent retailers 3,927 — — — 3,927 Supernatural 3,172 — — — 3,172 Retail — 1,273 — — 1,273 Other 1,128 — 116 — 1,244 Eliminations — — — ( 814 ) ( 814 ) Total $ 14,773 $ 1,273 $ 116 $ ( 814 ) $ 15,348 (1) Eliminations primarily includes the net sales elimination of Wholesale to Retail sales and the elimination of sales from segments included within Other to Wholesale. 11 Table of Contents The Company serves customers in the United States and Canada, as well as customers located in other countries. However, all of the Company’s revenue is earned in the United States and Canada, and international distribution occurs through freight-forwarders. The Company does not have any performance obligations on international shipments subsequent to delivery to the domestic port. Accounts and Notes Receivable Balances Accounts and notes receivable are as follows: (in millions) January 27, 2024 July 29, 2023 Customer accounts receivable $ 977 $ 887 Allowance for uncollectible receivables ( 17 ) ( 17 ) Other receivables, net 30 19 Accounts receivable, net $ 990 $ 889 Notes receivable, net, included within Prepaid expenses and other current assets $ 3 $ 3 Long-term notes receivable, net, included within Other long-term assets $ 7 $ 7 In fiscal 2023, the Company entered into an agreement to sell, on a revolving basis, certain customer accounts receivable to a third-party financial institution. Accounts receivable that the Company is servicing on behalf of the financial institution, which would have otherwise been outstanding as of January 27, 2024 and July 29, 2023, was approximately $ 333 million and $ 310 million, respectively. Net proceeds received are included within cash from operating activities in the Condensed Consolidated Statements of Cash Flows in the period of sale. The loss on sale of receivables was $ 5 million for the second quarters of fiscal 2024 and 2023, and $ 10 million and $ 5 million for fiscal 2024 and 2023 year-to-date, respectively, and is recorded within Loss (gain) on sale of assets and other asset charges in the Condensed Consolidated Statements of Operations. NOTE 4—PROPERTY AND EQUIPMENT, NET In fiscal 2024, the Company determined that it was more likely than not that it would dispose of one of its corporate-owned office locations before the end of its previously estimated useful life. As a result, the Company conducted an impairment review and recorded a $ 21 million non-cash asset impairment charge in fiscal 2024 year-to-date. The fair value utilized in the Company’s impairment review was determined based on the market approach. The impairment charge is recorded within Loss (gain) on sale of assets and other asset charges in the Condensed Consolidated Statements of Operations. There were no asset impairment charges recorded in the second quarter of fiscal 2024 and for fiscal 2023 year-to-date. NOTE 5—GOODWILL AND INTANGIBLE ASSETS, NET Changes in the carrying value of Goodwill by reportable segment that have goodwill consisted of the following: (in millions) Wholesale Other Total Goodwill as of July 29, 2023 $ 10 (1) $ 10 (2) $ 20 Change in foreign exchange rates — — — Goodwill as of January 27, 2024 $ 10 (1) $ 10 (2) $ 20 (1) Wholesale amounts are net of accumulated goodwill impairment charges of $ 717 million as of July 29, 2023 and January 27, 2024. (2) Other amounts are net of accumulated goodwill impairment charges of $ 10 million as of July 29, 2023 and January 27, 2024. 12 Table of Contents Identifiable intangible assets, net consisted of the following: January 27, 2024 July 29, 2023 (in millions) Gross Carrying Amount Accumulated Amortization Net Gross Carrying Amount Accumulated Amortization Net Amortizing intangible assets: Customer relationships $ 1,007 $ 383 $ 624 $ 1,007 $ 354 $ 653 Pharmacy prescription files 33 25 8 33 22 11 Operating lease intangibles 6 5 1 6 5 1 Trademarks and tradenames 88 61 27 89 57 32 Total amortizing intangible assets 1,134 474 660 1,135 438 697 Indefinite lived intangible assets: Trademarks and tradenames 25 — 25 25 — 25 Intangibles assets, net $ 1,159 $ 474 $ 685 $ 1,160 $ 438 $ 722 Amortization expense was $ 18 million for the second quarters of fiscal 2024 and 2023, respectively, and $ 36 million for fiscal 2024 and 2023 year-to-date, respectively. The estimated future amortization expense for each of the next five fiscal years and thereafter on amortizing intangible assets existing as of January 27, 2024 is as shown below: Fiscal Year: (in millions) Remaining fiscal 2024 $ 37 2025 71 2026 67 2027 64 2028 61 Thereafter 360 $ 660 NOTE 6—FAIR VALUE MEASUREMENTS OF FINANCIAL INSTRUMENTS Recurring Fair Value Measurements The following tables provide the fair value hierarchy for financial assets and liabilities measured on a recurring basis: Condensed Consolidated Balance Sheets Location Fair Value at January 27, 2024 (in millions) Level 1 Level 2 Level 3 Assets: Interest rate swaps designated as hedging instruments Prepaid expenses and other current assets $ — $ 13 $ — Interest rate swaps designated as hedging instruments Other long-term assets $ — $ 1 $ — Liabilities: Fuel derivatives designated as hedging instruments Accrued expenses and other current liabilities $ — $ 1 $ — Interest rate swaps designated as hedging instruments Other long-term liabilities $ — $ 1 $ — 13 Table of Contents Condensed Consolidated Balance Sheets Location Fair Value at July 29, 2023 (in millions) Level 1 Level 2 Level 3 Assets: Interest rate swaps designated as hedging instruments Prepaid expenses and other current assets $ — $ 17 $ — Interest rate swaps designated as hedging instruments Other long-term assets $ — $ 5 $ — Liabilities: Fuel derivatives designated as hedging instruments Accrued expenses and other current liabilities $ — $ 1 $ — Interest Rate Swap Contracts The fair values of interest rate swap contracts are measured using Level 2 inputs. The interest rate swap contracts are valued using an income approach interest rate swap valuation model incorporating observable market inputs including interest rates, SOFR swap rates and credit default swap rates. As of January 27, 2024, a 100-basis point increase in forward SOFR interest rates would increase the fair value of the interest rate swaps by approximately $ 11 million; a 100-basis point decrease in forward SOFR interest rates would decrease the fair value of the interest rate swaps by approximately $ 12 million. Refer to Note 7—Derivatives for further information on interest rate swap contracts. Fair Value Estimates For certain of the Company’s financial instruments including cash and cash equivalents, receivables, accounts payable, accrued vacation, compensation and benefits, and other current assets and liabilities the fair values approximate carrying amounts due to their short maturities. The fair value of notes receivable is estimated by using a discounted cash flow approach prior to consideration for uncollectible amounts and is calculated by applying a market rate for similar instruments using Level 3 inputs. The fair value of debt is estimated based on market quotes, where available, or market values for similar instruments, using Level 2 and 3 inputs. In the table below, the carrying value of the Company’s long-term debt is net of original issue discounts and debt issuance costs. January 27, 2024 July 29, 2023 (in millions) Carrying Value Fair Value Carrying Value Fair Value Notes receivable, including current portion $ 15 $ 9 $ 15 $ 8 Long-term debt, including current portion $ 2,180 $ 2,123 $ 1,963 $ 1,903 NOTE 7—DERIVATIVES Management of Interest Rate Risk The Company enters into interest rate swap contracts from time to time to mitigate its exposure to changes in market interest rates as part of its overall strategy to manage its debt portfolio to achieve an overall desired position of notional debt amounts subject to fixed and floating interest rates. Interest rate swap contracts are entered into for periods consistent with related underlying exposures and do not constitute positions independent of those exposures. The Company’s interest rate swap contracts are designated as cash flow hedges as of January 27, 2024. Interest rate swap contracts are reflected at their fair values in the Condensed Consolidated Balance Sheets. Refer to Note 6—Fair Value Measurements of Financial Instruments for further information on the fair value of interest rate swap contracts. 14 Table of Contents Details of active swap contracts as of January 27, 2024, which are all pay fixed and receive floating, are as follows: Effective Date Swap Maturity Notional Value (in millions) Pay Fixed Rate Receive Floating Rate Floating Rate Reset Terms January 11, 2019 March 28, 2024 100 2.3600 % One-Month Term SOFR Monthly January 23, 2019 March 28, 2024 100 2.4250 % One-Month Term SOFR Monthly November 30, 2018 October 31, 2024 100 2.7385 % One-Month Term SOFR Monthly January 11, 2019 October 31, 2024 100 2.4025 % One-Month Term SOFR Monthly January 24, 2019 October 31, 2024 50 2.4090 % One-Month Term SOFR Monthly October 26, 2018 October 22, 2025 50 2.8725 % One-Month Term SOFR Monthly November 16, 2018 October 22, 2025 50 2.8750 % One-Month Term SOFR Monthly November 16, 2018 October 22, 2025 50 2.8380 % One-Month Term SOFR Monthly January 24, 2019 October 22, 2025 50 2.4750 % One-Month Term SOFR Monthly December 29, 2023 June 3, 2027 100 3.7525 % One-Month Term SOFR Monthly December 29, 2023 June 3, 2027 100 3.7770 % One-Month Term SOFR Monthly $ 850 The Company performs an initial quantitative assessment of hedge effectiveness using the “Hypothetical Derivative Method” in the period in which the hedging transaction is entered. Under this method, the Company assesses the effectiveness of each hedging relationship by comparing the changes in cash flows of the derivative hedging instrument with the changes in cash flows of the designated hedged transactions. In future reporting periods, the Company performs a qualitative analysis for quarterly prospective and retrospective assessments of hedge effectiveness. The Company also monitors the risk of counterparty default on an ongoing basis and noted that the counterparties are reputable financial institutions. The entire change in the fair value of the derivative is initially reported in Other comprehensive income (outside of earnings) in the Condensed Consolidated Statements of Comprehensive (Loss) Income and subsequently reclassified to earnings in Interest expense, net in the Condensed Consolidated Statements of Operations when the hedged transactions affect earnings. The location and amount of gains or losses recognized in the Condensed Consolidated Statements of Operations for interest rate swap contracts for each of the periods, presented on a pre-tax basis, are as follows: 13-Week Period Ended 26-Week Period Ended January 27, 2024 January 28, 2023 January 27, 2024 January 28, 2023 (in millions) Interest expense, net Interest expense, net Total amounts of expense line items presented in the Condensed Consolidated Statements of Operations in which the effects of cash flow hedges are recorded $ 40 $ 39 $ 75 $ 74 Gain on cash flow hedging relationships: Gain reclassified from comprehensive income into earnings $ 5 $ 4 $ 10 $ 4 15 Table of Contents NOTE 8—LONG-TERM DEBT The Company’s long-term debt consisted of the following: (in millions) Average Interest Rate at January 27, 2024 Fiscal Maturity Year January 27, 2024 July 29, 2023 Term Loan Facility 8.72 % 2026 $ 645 $ 670 ABL Credit Facility 6.56 % 2027 1,054 812 Senior Notes 6.75 % 2029 500 500 Other secured loans 4.43 % 2025 4 9 Debt issuance costs, net ( 18 ) ( 22 ) Original issue discount on debt ( 5 ) ( 6 ) Long-term debt, including current portion 2,180 1,963 Less: current portion of long-term debt ( 4 ) ( 7 ) Long-term debt $ 2,176 $ 1,956 Senior Notes On October 22, 2020, the Company issued $ 500 million of unsecured 6.750 % senior notes due October 15, 2028 (the “Senior Notes”). The Senior Notes, which are presented net of debt issuance costs of $ 6 million as of January 27, 2024 in the Condensed Consolidated Balance Sheets, are guaranteed by each of the Company’s subsidiaries that are borrowers under or that guarantee the ABL Credit Facility or the Term Loan Facility (defined below). ABL Credit Facility The revolving credit agreement dated as of June 3, 2022 (the “ABL Loan Agreement”), by and among the Company (the “U.S. Borrower”) and UNFI Canada (the “Canadian Borrower” and, together with the U.S. Borrower, the “Borrowers”), and the financial institutions that are parties thereto as lenders (collectively, the “ABL Lenders”), Wells Fargo Bank, N.A. as administrative agent for the ABL Lenders, and the other parties thereto, provides for a secured asset-based revolving credit facility (the “ABL Credit Facility”), of which up to $ 2,600 million is available to the Borrowers, including a U.S. Dollar equivalent of $ 100 million sublimit for borrowings in Canadian dollars. Under the ABL Loan Agreement, the Borrowers may, at their option, increase the aggregate amount of the ABL Credit Facility in an amount of up to $ 750 million without the consent of any ABL Lenders not participating in such increase, subject to certain customary conditions and applicable lenders committing to provide the increase in funding. There is no assurance that additional funding would be available. The Borrowers’ obligations under the ABL Credit Facility are guaranteed by most of the Company’s wholly-owned subsidiaries (collectively, the “Guarantors”), subject to customary exceptions and limitations. The Borrowers’ obligations under the ABL Credit Facility and the Guarantors’ obligations under the related guarantees are secured by (i) a first-priority lien on certain accounts receivable, inventory and certain other assets arising therefrom or related thereto of the Borrowers and Guarantors (including substantially all of their deposit accounts, collectively, the “ABL Assets”) and (ii) a second-priority lien on all of the Borrowers’ and Guarantors’ assets that do not constitute ABL Assets, in each case, subject to customary exceptions and limitations. Availability under the ABL Credit Facility is subject to a borrowing base (the “Borrowing Base”), which is based on 90 % of eligible accounts receivable, plus 90 % of eligible credit card receivables, plus 90 % to 92.5 % of the net orderly liquidation value of eligible inventory, plus 90 % of eligible pharmacy receivables, plus certain availability related to pharmacy prescription files, after adjusting for customary reserves, but at no time shall exceed the lesser of the aggregate commitments under the ABL Credit Facility (currently $ 2,600 million) or the Borrowing Base. 16 Table of Contents The assets included in the Condensed Consolidated Balance Sheets securing the outstanding obligations under the ABL Credit Facility on a first-priority basis were as follows: (in millions) January 27, 2024 July 29, 2023 Certain inventory assets included in Inventories, net $ 1,850 $ 1,861 Certain receivables included in Accounts receivable, net 584 571 Pharmacy prescription files included in Intangible assets, net 8 11 Total $ 2,442 $ 2,443 As of January 27, 2024, the Borrowers’ Borrowing Base was $ 2,606 million, reflecting the advance rates described above and $ 105 million of reserves, which is above the $ 2,600 million limit of availability. This resulted in total availability of $ 2,600 million for loans and letters of credit under the ABL Credit Facility. The Company’s unused credit under the ABL Credit Facility was as follows: (in millions) January 27, 2024 Total availability for ABL loans and letters of credit $ 2,600 ABL loans outstanding ( 1,054 ) Letters of credit outstanding ( 150 ) Unused credit $ 1,396 The applicable interest rates, unutilized commitment fees and letter of credit fees under the ABL Credit Facility are variable and are dependent upon the prior fiscal quarter’s daily Average Availability (as defined in the ABL Loan Agreement), and were as follows: Range of Facility Rates and Fees (per annum) January 27, 2024 Borrowers’ applicable margin for base rate loans 0.00 % - 0.25 % 0.00 % Borrowers’ applicable margin for SOFR and BA loans (1) 1.00 % - 1.25 % 1.00 % Unutilized commitment fees 0.20 % 0.20 % Letter of credit fees 1.125 % - 1.375 % 1.125 % (1) The U.S. Borrower utilizes SOFR-based loans and the Canadian Borrower utilizes bankers’ acceptance rate-based loans. Term Loan Facility The term loan agreement dated as of October 22, 2018 (as amended, the “Term Loan Agreement”), by and among the Company and SUPERVALU INC. (“Supervalu” and, collectively with the Company, the “Term Borrowers”), the financial institutions that are parties thereto as lenders (collectively, the “Term Lenders”), Credit Suisse, as administrative agent for the Term Lenders, and the other parties thereto, provides for a $ 1,800 million senior secured first lien term loan (the “Term Loan Facility”). The net proceeds from the Term Loan Facility were used to finance the Supervalu acquisition and related transaction costs. Any amounts then outstanding will be payable in full on October 22, 2025. The obligations under the Term Loan Facility are guaranteed by the Guarantors, subject to customary exceptions and limitations. The Term Borrowers’ obligations under the Term Loan Facility and the Guarantors’ obligations under the related guarantees are secured by (i) a first-priority lien on substantially all of the Term Borrowers’ and the Guarantors’ assets other than the ABL Assets and (ii) a second-priority lien on substantially all of the Term Borrowers’ and the Guarantors’ ABL Assets, in each case, subject to customary exceptions and limitations, including an exception for owned real property with net book values of less than $ 10 million. As of January 27, 2024 and July 29, 2023, there was $ 608 million and $ 617 million, respectively, of owned real property pledged as collateral that was included in Property and equipment, net in the Condensed Consolidated Balance Sheets. The Company must prepay loans outstanding under the Term Loan Facility no later than 130 days after the fiscal year end in an aggregate principal amount equal to a specified percentage (which percentage ranges from 0 to 75 percent depending on the Consolidated First Lien Net Leverage Ratio as of the last day of such fiscal year) of Excess Cash Flow (as defined in the Term Loan Agreement), minus certain types of voluntary prepayments of indebtedness made during such fiscal year. The potential amount of prepayment from Excess Cash Flow in fiscal 2024 that may be required in fiscal 2025 is not reasonably estimable as of January 27, 2024. 17 Table of Contents As of January 27, 2024, the Company had borrowings of $ 645 million outstanding under the Term Loan Facility, which are presented in the Condensed Consolidated Balance Sheets net of debt issuance costs of $ 5 million and an original issue discount on debt of $ 5 million. As of January 27, 2024, no amount of the Term Loan Facility was classified as current. As of January 27, 2024, the borrowings under the Term Loan Facility bear interest at rates that, at the Term Borrowers’ option, can be either: (i) a base rate plus a margin of 2.25 % or (ii) a SOFR rate plus a margin of 3.25 %, provided that the SOFR rate shall never be less than 0.0 %. NOTE 9—COMPREHENSIVE (LOSS) INCOME AND ACCUMULATED OTHER COMPREHENSIVE LOSS Changes in Accumulated other comprehensive loss by component, net of tax, for fiscal 2024 year-to-date were as follows: (in millions) Other Cash Flow Derivatives Benefit Plans Foreign Currency Translation Swap Agreements Total Accumulated other comprehensive (loss) income at July 29, 2023 $ — $ ( 21 ) $ ( 21 ) $ 14 $ ( 28 ) Other comprehensive loss before reclassifications — — ( 1 ) — ( 1 ) Amortization of amounts included in net periodic benefit income — 1 — — 1 Amortization of cash flow hedges — — — ( 7 ) ( 7 ) Net current period Other comprehensive income (loss) — 1 ( 1 ) ( 7 ) ( 7 ) Accumulated other comprehensive (loss) income at January 27, 2024 $ — $ ( 20 ) $ ( 22 ) $ 7 $ ( 35 ) Changes in Accumulated other comprehensive loss by component, net of tax, for fiscal 2023 year-to-date were as follows: (in millions) Other Cash Flow Derivatives Benefit Plans Foreign Currency Translation Swap Agreements Total Accumulated other comprehensive income (loss) at July 30, 2022 $ 2 $ ( 3 ) $ ( 19 ) $ — $ ( 20 ) Other comprehensive (loss) income before reclassifications ( 3 ) — ( 2 ) 17 12 Amortization of amounts included in net periodic benefit income — 1 — — 1 Amortization of cash flow hedges 1 — — ( 3 ) ( 2 ) Net current period Other comprehensive (loss) income ( 2 ) 1 ( 2 ) 14 11 Accumulated other comprehensive income (loss) at January 28, 2023 $ — $ ( 2 ) $ ( 21 ) $ 14 $ ( 9 ) 18 Table of Contents Items reclassified out of Accumulated other comprehensive loss had the following impact on the Condensed Consolidated Statements of Operations: 13-Week Period Ended 26-Week Period Ended Affected Line Item on the Condensed Consolidated Statements of Operations (in millions) January 27, 2024 January 28, 2023 January 27, 2024 January 28, 2023 Pension and postretirement benefit plan net assets: Amortization of amounts included in net periodic benefit income (1) $ 1 $ 1 $ 1 $ 1 Net periodic benefit income, excluding service cost Income tax expense (benefit) — — — — (Benefit) provision for income taxes Total reclassifications, net of tax $ 1 $ 1 $ 1 $ 1 Swap agreements: Reclassification of cash flow hedges $ ( 5 ) $ ( 4 ) $ ( 10 ) $ ( 4 ) Interest expense, net Income tax expense 2 1 3 1 (Benefit) provision for income taxes Total reclassifications, net of tax $ ( 3 ) $ ( 3 ) $ ( 7 ) $ ( 3 ) Other cash flow hedges: Reclassification of cash flow hedge $ — $ 1 $ — $ 2 Cost of sales Income tax benefit — ( 1 ) — ( 1 ) (Benefit) provision for income taxes Total reclassifications, net of tax $ — $ — $ — $ 1 (1) Reclassification of amounts included in net periodic benefit income include reclassification of prior service cost as reflected in Note 11—Benefit Plans. As of January 27, 2024, the Company expects to reclassify $ 11 million related to unrealized derivative gains out of Accumulated other comprehensive loss and primarily into Interest expense, net during the following twelve-month period. NOTE 10—SHARE-BASED AWARDS In fiscal 2024 year-to-date, the Company granted restricted stock units and performance share units to its directors, executive officers and certain employees representing a right to receive an aggregate of 3.3 million shares. As of January 27, 2024, there were 1.7 million shares available for issuance under the Third Amended and Restated 2020 Equity Incentive Plan. NOTE 11—BENEFIT PLANS Net periodic benefit (income) cost and contributions to defined benefit pension and other postretirement benefit plans consisted of the following: 13-Week Period Ended Pension Benefits Other Postretirement Benefits (in millions) January 27, 2024 January 28, 2023 January 27, 2024 January 28, 2023 Interest cost $ 18 $ 15 $ — $ — Expected return on plan assets ( 23 ) ( 23 ) — — Amortization of prior service cost — — 1 1 Net periodic benefit (income) cost $ ( 5 ) $ ( 8 ) $ 1 $ 1 Contributions to benefit plans $ — $ — $ — $ — 19 Table of Contents 26-Week Period Ended Pension Benefits Other Postretirement Benefits (in millions) January 27, 2024 January 28, 2023 January 27, 2024 January 28, 2023 Interest cost $ 37 $ 32 $ — $ — Expected return on plan assets ( 45 ) ( 47 ) — — Amortization of prior service cost — — 1 1 Net periodic benefit (income) cost $ ( 8 ) $ ( 15 ) $ 1 $ 1 Contributions to benefit plans $ — $ — $ — $ — Contributions No minimum pension contributions are required to be made to the SUPERVALU INC. Retirement Plan under the Employee Retirement Income Security Act of 1974, as amended, (“ERISA”) in fiscal 2024. The Company expects to contribute approximately $ 1 million to its other defined benefit pension plans and $ 1 million to its postretirement benefit plans in fiscal 2024. Multiemployer Pension Plans The Company contributed $ 13 million and $ 12 million in the second quarters of fiscal 2024 and 2023, respectively, and $ 26 million and $ 23 million in fiscal 2024 and 2023 year-to-date, respectively, to multiemployer pension plans, which contributions are included within Operating expenses. NOTE 12—INCOME TAXES The effective tax rate for the second quarter of fiscal 2024 was a benefit rate of 26.3 % on pre-tax loss compared to an expense rate of 29.0 % on pre-tax income for the second quarter of fiscal 2023. The change from the second quarter of fiscal 2023 is primarily driven by the reduction in pre-tax income during the second quarter of fiscal 2023. The effective tax rate for fiscal 2024 year-to-date was a benefit rate of 20.9 % on pre-tax loss compared to an expense rate of 13.6 % on pre-tax income for fiscal 2023 year-to-date. The change from fiscal 2023 year-to-date is primarily driven by the reduction of discrete tax benefits related to employee stock award vestings in the first quarter of fiscal 2024. In addition, the first quarter of fiscal 2023 included a tax benefit from the release of reserves for unrecognized tax positions that did not recur in the first quarter of fiscal 2024. The primary drivers for the variation between the Company’s statutory tax rate and its effective tax rate for fiscal 2024 and fiscal 2023 year-to-date were discrete tax detriments and benefits, respectively, resulting from share award vestings. 20 Table of Contents NOTE 13—EARNINGS PER SHARE The following is a reconciliation of the basic and diluted number of shares used in computing earnings per share: 13-Week Period Ended 26-Week Period Ended (in millions, except per share data) January 27, 2024 January 28, 2023 January 27, 2024 January 28, 2023 Basic weighted average shares outstanding 59.4 59.8 59.0 59.3 Net effect of dilutive stock awards based upon the treasury stock method — 1.2 — 2.0 Diluted weighted average shares outstanding 59.4 61.0 59.0 61.3 Basic (loss) earnings per share (1) $ ( 0.25 ) $ 0.32 $ ( 0.92 ) $ 1.43 Diluted (loss) earnings per share (1) $ ( 0.25 ) $ 0.31 $ ( 0.92 ) $ 1.38 Anti-dilutive share-based awards excluded from the calculation of diluted (loss) earnings per share 2.2 0.8 2.0 0.8 (1) (Loss) earnings per share amounts are calculated using actual unrounded figures. NOTE 14—BUSINESS SEGMENTS The Company has two reportable segments: Wholesale and Retail. These reportable segments are two distinct businesses, each with a different customer base, marketing strategy and management structure. The Company organizes and operates the Wholesale reportable segment through three U.S geographic regions: East, Central and West, and Canada Wholesale, which is operated separately from the U.S. Wholesale business. The U.S. Wholesale and Canada Wholesale operating segments have similar products and services, customer channels, distribution methods and economic characteristics, and therefore have been aggregated into a single reportable segment. Reportable segments are reviewed on an annual basis, or more frequently if events or circumstances indicate a change in reportable segments has occurred. 21 Table of Contents The following table provides information by reportable segment, including Net sales, Adjusted EBITDA, with a reconciliation to (Loss) income before income taxes, depreciation and amortization, and payments for capital expenditures: 13-Week Period Ended 26-Week Period Ended (in millions) January 27, 2024 January 28, 2023 January 27, 2024 January 28, 2023 Net sales: Wholesale (1) $ 7,487 $ 7,514 $ 14,768 $ 14,773 Retail 631 660 1,237 1,273 Other 52 56 112 116 Eliminations ( 395 ) ( 414 ) ( 790 ) ( 814 ) Total Net sales $ 7,775 $ 7,816 $ 15,327 $ 15,348 Adjusted EBITDA: Wholesale $ 118 $ 137 $ 235 $ 308 Retail 8 28 7 48 Other 4 15 7 34 Eliminations ( 2 ) 1 ( 4 ) ( 2 ) Adjustments: Net income attributable to noncontrolling interests 1 3 1 4 Net periodic benefit income, excluding service cost 4 7 7 14 Interest expense, net ( 40 ) ( 39 ) ( 75 ) ( 74 ) Other income, net 1 — 1 1 Depreciation and amortization ( 74 ) ( 73 ) ( 152 ) ( 147 ) Share-based compensation ( 10 ) ( 11 ) ( 16 ) ( 23 ) LIFO charge ( 6 ) ( 29 ) ( 13 ) ( 50 ) Restructuring, acquisition and integration related expenses ( 4 ) ( 3 ) ( 8 ) ( 5 ) (Loss) gain on sale of assets and other asset charges ( 5 ) ( 1 ) ( 24 ) 4 Business transformation costs ( 14 ) ( 4 ) ( 29 ) ( 9 ) Other adjustments — — ( 4 ) — (Loss) income before income taxes $ ( 19 ) $ 31 $ ( 67 ) $ 103 Depreciation and amortization: Wholesale $ 66 $ 62 $ 133 $ 126 Retail 8 10 16 18 Other — 1 3 3 Total depreciation and amortization $ 74 $ 73 $ 152 $ 147 Payments for capital expenditures: Wholesale $ 64 $ 74 $ 135 $ 131 Retail 3 10 6 20 Total capital expenditures $ 67 $ 84 $ 141 $ 151 (1) As presented in Note 3—Revenue Recognition, the Company recorded $ 330 million and $ 353 million for the second quarters of fiscal 2024 and 2023, respectively, and $ 651 million and $ 687 million in fiscal 2024 and 2023 year-to-date, respectively, within Net sales in its Wholesale reportable segment attributable to Wholesale to Retail sales that have been eliminated upon consolidation. 22 Table of Contents Total assets by reportable segment were as follows: (in millions) January 27, 2024 July 29, 2023 Assets: Wholesale $ 6,718 $ 6,405 Retail 630 648 Other 372 377 Eliminations ( 49 ) ( 36 ) Total assets $ 7,671 $ 7,394 NOTE 15—COMMITMENTS, CONTINGENCIES AND OFF-BALANCE SHEET ARRANGEMENTS Guarantees and Contingent Liabilities The Company has outstanding guarantees related to certain leases, fixture financing loans and other debt obligations of various retailers as of January 27, 2024. These guarantees were generally made to support the business growth of wholesale customers. The guarantees are generally for the entire terms of the leases, fixture financing loans or other debt obligations with remaining terms that range from less than one year to seven years , with a weighted average remaining term of approximately four years . For each guarantee issued, if the wholesale customer or other third-party defaults on a payment, the Company would be required to make payments under its guarantee. Generally, the guarantees are secured by indemnification agreements or personal guarantees. The Company reviews performance risk related to its guarantee obligations based on internal measures of credit performance. As of January 27, 2024, the maximum amount of undiscounted payments the Company would be required to make in the event of default of all guarantees was $ 11 million ($ 9 million on a discounted basis). Based on the indemnification agreements, personal guarantees and results of the reviews of performance risk, as of January 27, 2024, a total estimated loss of less than $ 1 million is recorded in the Condensed Consolidated Balance Sheets. The Company is a party to a variety of contractual agreements under which it may be obligated to indemnify the other party for certain matters in the ordinary course of business, which indemnities may be secured by operation of law or otherwise. These agreements primarily relate to the Company’s commercial contracts, service agreements, contracts entered into for the purchase and sale of stock or assets, operating leases and other real estate contracts, financial agreements, agreements to provide services to the Company and agreements to indemnify officers, directors and employees in the performance of their work. While the Company’s aggregate indemnification obligations could result in a material liability, the Company is not aware of any matters that are expected to result in a material liability. No amount has been recorded in the Condensed Consolidated Balance Sheets for these contingent obligations as the fair value has been determined to be de minimis. In connection with Supervalu’s sale of New Albertson’s, Inc. (“NAI”) on March 21, 2013, the Company remains contingently liable with respect to certain self-insurance commitments and other guarantees as a result of parental guarantees issued by Supervalu with respect to the obligations of NAI that were incurred while NAI was Supervalu’s subsidiary. Based on the expected settlement of the self-insurance claims that underlie the Company’s commitments, the Company believes that such contingent liabilities will continue to decline. Subsequent to the sale of NAI, NAI collateralized most of these obligations with letters of credit and surety bonds to numerous state governmental authorities. Because NAI remains a primary obligor on these self-insurance and other obligations and has collateralized most of the self-insurance obligations for which the Company remains contingently liable, the Company believes that the likelihood that it will be required to assume a material amount of these obligations is remote. Accordingly, no amount has been recorded in the Condensed Consolidated Balance Sheets for these guarantees, as the fair value has been determined to be de minimis. 23 Table of Contents Agreements with Save-A-Lot and Onex The Agreement and Plan of Merger pursuant to which Supervalu sold the Save-A-Lot business in 2016 (the “SAL Merger Agreement”) contains customary indemnification obligations of each party with respect to breaches of their respective representations, warranties and covenants, and certain other specified matters, on the terms and subject to the limitations set forth in the SAL Merger Agreement. Similarly, Supervalu entered into a Separation Agreement (the “Separation Agreement”) with Moran Foods, LLC d/b/a Save-A-Lot (“Moran Foods”), which contains indemnification obligations and covenants related to the separation of the assets and liabilities of the Save-A-Lot business from the Company. The Company also entered into a Services Agreement with Moran Foods (the “Services Agreement”), pursuant to which the Company provided Save-A-Lot with various technical, human resources, finance and other operational services. The Company primarily ceased providing services under the Services Agreement in fiscal 2022. The Services Agreement generally requires each party to indemnify the other party against third-party claims arising out of the performance of or the provision or receipt of services under the Services Agreement. While the Company’s aggregate indemnification obligations to Save-A-Lot and Onex, the purchaser of Save-A-Lot, could result in a material liability, the Company is not aware of any matters that are expected to result in a material liability. The Company has recorded the de minimis fair value of the guarantee in the Condensed Consolidated Balance Sheets within Other long-term liabilities. Other Contractual Commitments In the ordinary course of business, the Company enters into supply contracts to purchase products for resale and service contracts for fixed asset and information technology systems. These contracts typically include either volume commitments or fixed expiration dates, termination provisions and other standard contractual considerations. As of January 27, 2024, the Company had approximately $ 657 million of non-cancelable future purchase obligations, most of which will be paid and utilized in the ordinary course within one year. As of January 27, 2024, the Company had commitments of $ 323 million for future undiscounted minimum lease payments on leases signed but not yet commenced with terms of up to 21 years from commencement date. A lease agreement for a facility in Manchester, Pennsylvania entered into in fiscal 2023 commenced in the second quarter of fiscal 2024 resulting in the recognition of a $ 205 million right-of-use asset and operating lease liability in the Condensed Consolidated Balance Sheets. Legal Proceedings The Company is one of dozens of companies that have been named in various lawsuits alleging that drug manufacturers, retailers and distributors contributed to the national opioid epidemic. Currently, UNFI, primarily through its subsidiary, Advantage Logistics, is named in approximately 43 suits pending in the United States District Court for the Northern District of Ohio where thousands of cases have been consolidated as Multi-District Litigation (“MDL”). In accordance with the Stock Purchase Agreement dated January 10, 2013, between New Albertson’s Inc. (“New Albertson’s”) and the Company (the “Stock Purchase Agreement”), New Albertson’s is defending and indemnifying UNFI in a majority of the cases under a reservation of rights as those cases relate to New Albertson’s pharmacies. In one of the MDL cases, MDL No. 2804 filed by The Blackfeet Tribe of the Blackfeet Indian Reservation, all defendants were ordered to Answer the Complaint, which UNFI did on July 26, 2019. To date, no discovery has been conducted against UNFI in any of the actions. On October 7, 2022, the MDL Court issued an order directing the Company and numerous other “non-litigating” defendants to submit by November 1, 2022, a list of opioid cases where the Company is named and opioid dispensing and distribution data. The Company produced the data in compliance with the order. On March 8, 2023, the Company received a subpoena from the Consumer Protection Division of the Maryland Attorney General’s Office seeking records related to the distribution and dispensing of opioids. On May 19, 2023, the Company provided an initial production in response to the subpoena and is in the process of gathering additional responsive documents. The Company believes these claims are without merit and intends to vigorously defend this matter. 24 Table of Contents On January 21, 2021, various health plans filed a complaint in Minnesota state court against the Company, Albertson’s Companies, LLC (“Albertson’s”) and Safeway, Inc. alleging the defendants committed fraud by improperly reporting inflated prices for prescription drugs for members of health plans. The Plaintiffs assert six causes of action against the defendants: common law fraud, fraudulent nondisclosure, negligent misrepresentation, unjust enrichment, violation of the Minnesota Uniform Deceptive Trade Practices Act and violation of the Minnesota Prevention of Consumer Fraud Act. The plaintiffs allege that between 2006 and 2016, Supervalu overcharged the health plans by not providing the health plans, as part of usual and customary prices, the benefit of discounts given to customers purchasing prescription medication who requested that Supervalu match competitor prices. Plaintiffs seek an unspecified amount of damages. Similar to the above case, for the majority of the relevant period Supervalu and Albertson’s operated as a combined company. In March 2013, Supervalu divested Albertson’s and pursuant to the Stock Purchase Agreement, Albertson’s is responsible for any claims regarding its pharmacies. On February 19, 2021, Albertson’s and Safeway removed the case to Minnesota Federal District Court, and on March 22, 2021, plaintiffs filed a motion to remand to state court. On February 26, 2021, defendants filed a motion to dismiss. The hearing on the remand motion and motions to dismiss occurred on May 20, 2021. On September 21, 2021, the Federal District Court remanded the case to Minnesota state court and did not rule on the motion to dismiss, which was refiled in state court. On February 1, 2022, the state court denied the motion to dismiss. On November 27, 2023, the court held a scheduling conference and thereafter entered a scheduling order setting various discovery and expert deadlines. The trial date is set for July 21, 2025. The Company believes these claims are without merit and is vigorously defending this matter. UNFI is currently subject to a qui tam action alleging violations of the False Claims Act (“FCA”). In United States ex rel. Schutte and Yarberry v. Supervalu, New Albertson’s, Inc., et al, which is pending in the U.S. District Court for the Central District of Illinois, the relators allege that defendants overcharged government healthcare programs by not providing the government, as a part of usual and customary prices, the benefit of discounts given to customers purchasing prescription medication who requested that defendants match competitor prices. The complaint was originally filed under seal and amended on November 30, 2015. The government previously investigated the relators’ allegations and declined to intervene. Violations of the FCA are subject to treble damages and penalties of up to a specified dollar amount per false claim. The relators elected to pursue the case on their own and have alleged FCA damages against Supervalu and New Albertson’s in excess of $ 100 million, not including trebling and statutory penalties. For the majority of the relevant period Supervalu and New Albertson’s operated as a combined company. In March 2013, Supervalu divested New Albertson’s (and related assets) pursuant to the Stock Purchase Agreement. Based on the claims that are currently pending and the Stock Purchase Agreement, Supervalu’s share of a potential award (at the currently claimed value by the relators) would be approximately $ 24 million, not including trebling and statutory penalties. Both sides moved for summary judgment. On August 5, 2019, the Court granted one of the relators’ summary judgment motions finding that the defendants’ lower matched prices are the usual and customary prices and that Medicare Part D and Medicaid were entitled to those prices. On July 2, 2020, the Court granted the defendants’ summary judgment motion and denied the relators’ motion, dismissing the case. On July 9, 2020, the relators filed a notice of appeal with the Seventh Circuit Court of Appeals. On August 12, 2021, the Seventh Circuit affirmed the District Court’s decision granting summary judgment in defendants’ favor. On September 23, 2021, the relators filed a petition for rehearing which was denied on December 3, 2021. On April 1, 2022, the relators filed a petition for a writ of certiorari with the United States Supreme Court which was granted on January 13, 2023. On June 1, 2023, the Supreme Court reversed and vacated the lower court’s judgment and remanded the case to the Seventh Circuit for further proceedings. On July 27, 2023, the Seventh Circuit vacated the summary judgment order and remanded the case to the District Court. On August 22, 2023, the District Court set the trial date for April 29, 2024. On October 11, 2023, each of the Company and the relators filed a motion for summary judgment. Briefing is complete and oral argument is scheduled for May 20, 2024. On February 16, 2024, the defendants filed a motion to reconsider the Court’s August 5, 2019 partial grant of summary judgment to the relators and to continue the trial date. On February 27, 2024, the Court granted the defendants’ motion for a trial date continuance and vacated the April 29, 2024 trial date. The trial is now scheduled to begin September 30, 2024. From time to time, the Company receives notice of claims or potential claims or becomes involved in litigation, alternative dispute resolution, such as arbitration, or other legal and regulatory proceedings that arise in the ordinary course of its business, including investigations and claims regarding employment law, including wage and hour (including class actions); pension plans; labor union disputes, including unfair labor practices, such as claims for back-pay in the context of labor contract negotiations and other matters; supplier, customer and service provider contract terms and claims, including matters related to supplier or customer insolvency or general inability to pay obligations as they become due; product liability claims, including those where the supplier may be insolvent and customers or consumers are seeking recovery against the Company; real estate and environmental matters, including claims in connection with its ownership and lease of a substantial amount of real property, both retail and warehouse properties; and antitrust. Other than as described above, there are no pending material legal proceedings to which the Company is a party or to which its property is subject. 25 Table of Contents Predicting the outcomes of claims and litigation and estimating related costs and exposures involves substantial uncertainties that could cause actual outcomes, costs and exposures to vary materially from current expectations. Management regularly monitors the Company’s exposure to the loss contingencies associated with these matters and may from time to time change its predictions with respect to outcomes and estimates with respect to related costs and exposures. As of January 27, 2024, no material accrued obligations, individually or in the aggregate, have been recorded for these legal proceedings. Although management believes it has made appropriate assessments of potential and contingent loss in each of these cases based on current facts and circumstances, and application of prevailing legal principles, there can be no assurance that material differences in actual outcomes from management’s current assessments, costs and exposures relative to current predictions and estimates, or material changes in such predictions or estimates will not occur. The occurrence of any of the foregoing could have a material adverse effect on the Company’s financial condition, results of operations or cash flows. 26 Table of Contents